Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Targeting the Conventional Outflow System

Mark Gallardo, MD, sits down with Inder Paul Singh, MD, to talk about latanoprostene bunod ophthalmic solution 0.024% (Vyzulta, Bausch + Lomb). Learn more about this molecule and how it differs from other commercially available agents.

2 / 6 Series: Dose and Delivery